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Abstract
Spleen stromal lines which support in vitro hematopoiesis are investigated for their lineage
origin and hematopoietic support function in vivo. Marker expression and gene profiling
identify a lineage relationship with mesenchymal stem cells and perivascular reticular cells
described recently in bone marrow. Stromal lines commonly express Cxcl12, Pdgfra and
Pdgfr typical of bone marrow derived perivascular reticular cells but reflect a unique cell type
in terms of other gene and marker expression. Their classification as osteoprogenitors is
confirmed through ability to undergo osteogenic, but not adipogenic or chondrogenic differ-
entiation. Some stromal lines were shown to form ectopic niches for HSCs following engraft-
ment under the kidney capsule of NOD/SCID mice. The presence of myeloid cells and a
higher representation of a specific dendritic-like cell type over other myeloid cells within
grafts was consistent with previous in vitro evidence of hematopoietic support capacity.
These studies reinforce the role of perivascular/perisinusoidal reticular cells in hematopoie-
sis and implicate such cells as niches for hematopoiesis in spleen.
Introduction
Both mouse and human spleen retain low numbers of long-term resident hematopoietic stem
cells (HSCs) [1–4] suggesting that the spleen may play a ‘steady-state’ hematopoietic role.
Spleen also supports extramedullary hematopoiesis driven by stress or infection when HSCs
mobilize out of bone marrow and into blood and peripheral tissues like spleen, liver and brain
[5]. Hematopoiesis in spleen occurs in the sinusoidal-rich red pulp region, supported by evi-
dence that mobilized HSCs entering spleen from bone marrow via blood localize in the red
pulp, and that mature myeloid cells are abundant in red pulp [6].
Recent studies have identified PDGFR+ perisinusoidal stromal cells in the red pulp region
of murine spleen in association with HSCs under conditions of extramedullary hematopoiesis
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[7]. Mesenchymal progenitor-like cells overexpressing Hox11 have also been shown to selec-
tively localize in the perifollicular region of red pulp of murine spleen as a source of HSC niche
factors [8]. While evidence for HSC niches in spleen is increasing, very little is known about
the stromal cells which support hematopoiesis and the hematopoietic cells which are pro-
duced, and whether these represent the full spectrum of blood cells, or restricted hematopoietic
cell development. Studies from this lab have also identified a role for spleen in the production
of a distinct dendritic-like cell type ‘L-DC’ which has been detected in both human and murine
spleen [9–11]. These observations reinforce spleen as both an active site for hematopoiesis and
as a reservoir for developing myeloid cells.
We have investigated the role of splenic stroma in hematopoiesis since it was first discov-
ered that long-term spleen cultures can support hematopoiesis [12]. Splenic stromal lines over-
laid with hematopoietic progenitors, support long-term in vitro cultures with production of
distinct myeloid cells [13]. Cultures give transient production of several myeloid cell types
including cells resembling conventional dendritic cells (cDC), along with continuous produc-
tion of the distinct subset identified as ‘L-DC’ [14]. Hematopoietic progenitors are maintained
in long-term spleen cultures, evident through marker and gene expression studies [15, 16],
and through ability to transfer long-term reconstitution upon adoptive transfer of cells into
irradiated host mice [17].
A number of splenic stromal lines were isolated from long-term spleen cultures which were
subsequently shown to support hematopoiesis in overlaid bone marrow progenitors [18, 19].
The STX3 splenic stromal cell line was derived from a long-term culture of spleen which had
lost hematopoietic cells with passage over many years [20]. Multiple clonal lines were estab-
lished from STX3 [18, 21], and several were shown to support hematopoiesis when overlaid
with hematopoietic progenitors derived from fetal liver or bone marrow [13, 19, 22–24]. In
particular, STX3, 5G3, 2A8, 10C9 and 7G10 stroma are reliable in vitro supporters of hemato-
poiesis [25] and 5G3 has been used in many studies to date [26, 27]. These cells specifically
support the continuous production of L-DC from retained progenitors, and the transient pro-
duction of other myeloid cells [23, 28]. In contrast, 3B5 is a non-supporter of hematopoiesis in
vitro [25]. In particular, 5G3 has supports hematopoiesis when overlaid with sorted bone mar-
row-derived HSCs or multipotential progenitors (MPPs), with production of only L-DCs [24].
These stromal lines can also support common myeloid progenitors (CMPs) or common den-
dritic progenitors (CDPs), but give only transient production of myeloid cells and no long-
term L-DC production [13]. Consistent with these findings is evidence that CD146+ perivascu-
lar cells from human adipose tissue can maintain HSCs in co-cultures [29].
Splenic stromal lines including STX3, 5G3, 3B5, 7G10, 2A8 and 10C9 are characterized
here in terms of their individual lineage origin and similarity with perivascular reticular stro-
mal cell types reported in bone marrow. In terms of lineage origin, the 5G3 supporter line is
compared with the 3B5 non-supporter 3B5 line. Stromal lines are also for their ability to form
an ectopic niche in vivo as a more physiological test of hematopoietic support capacity.
Materials and methods
Animals
Specific pathogen-free C57BL/6J (H-2Kb: CD45.2) mice aged 4 to 8 weeks and NOD/SCID (H-
2Kd: CD45.1) mice aged between 6 and 9 weeks, were obtained from the John Curtin School of
Medical Research (JCSMR: Canberra, ACT, Australia). Mice were housed and handled according
to protocols approved by the Animal Experimentation Ethics Committee at the Australian
National University (ANU: Canberra, ACT, Australia). Experimentation followed the guidelines
of the Australian code for the care and use of animals for scientific purposes 8th Edition (2013).
Hematopoiesis in spleen
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Stromal cell cultures
The 5G3, 3B5, 7G10, 2A8 and 10C9 stromal lines were cloned from STX3 splenic stroma
derived from a long-term culture of spleen from B10.A(2R) mice (H-2Kk) [18, 21, 30]. Stromal
cell lines were grown from frozen stocks and passaged up to five times by transfer of cells to
new flasks following trypsinization using 0.25% trypsin-EDTA treatment to dissociate cells.
Stromal cells were cultured at 37˚C in 5% CO2 in air in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum, 5x10-4M 2-mercaptoethanol, 10mM
HEPES, 100U/ml penicillin, 100g/ml streptomycin, 4mg/l glucose, 6mg/l folic acid, 36mg/l L-
asparagine and 116mg/l L-asparagine hydrochloric acid (sDMEM).
Enrichment of myeloid lineage cells and progenitors
Single cell suspensions of spleen were prepared by forcing tissue through a fine wire grid, fol-
lowed by lysis of red blood cells through exposure to isotonic buffer (140mM NH4CL, 17mM
Tris Base [pH 7.5]). MACS1magnetic bead technology (Miltenyi Biotec: Gladbach, Ger-
many) was used to prepare T and B cell depleted splenocytes as described previously [28]. Fol-
lowing exposure of spleen leukocytes to biotinylated antibodies specific for CD19 and Thy1.2,
cells were passed through LS or MS columns (Miltenyi Biotec) containing anti-biotin
MACS1magnetic beads placed in a SuperMACS1magnetic separator (Miltenyi Biotec).
Flow-through cells were washed through and collected for experimentation.
Establishment of co-cultures
The capacity of stromal lines to support hematopoiesis was assessed by overlay of myeloid cells
and progenitors above stromal cell monolayers grown to 80–90% confluency followed by co-
culture for several weeks [19, 23, 28]. T and B cell depleted splenocytes were prepared and
plated at 1–5 x 104 cells/ml in flasks containing stromal cell monolayers. Co-cultures were held
at 37˚C, 5% CO2 in air and 97% humidity. At 7-day intervals, non-adherent cells were col-
lected by gently shaking the flask with removal and replacement of supernatant. Cell yield was
determined by counting and cells analyzed for surface marker expression by antibody staining
and flow cytometric analysis.
Light microscopy
Microscopy was used to assess cell morphology. Cells were observed and photographed by
bright-field and inverted phase contrast microscopy using a DMIRE2 inverted research micro-
scope (Leica: North Ryde, NSW, Australia) equipped with a DFC digital camera (Leica).
Immunofluorescence microscopy
Tissue was embedded in Tissue-Tek OCTTM compound (10.24% polyvinyl alcohol, 4.26%
polyethylene glycol, 85.50% non-reactive ingredient) and sections of 10μm thickness prepared
using a Reichert-Jung 2800 Frigocut cryostat (Reichert-Jung: Depew, New York, USA). Sec-
tions were acetone-fixed for 15 minutes at 4˚C and air dried for an hour before storage at
-80˚C. Frozen sections were left to thaw at room temperature before staining. Tissue sections
were first blocked with 10% heat inactivated fetal calf serum in PBS for 45 minutes at room
temperature and then stained with fluorochrome-labelled antibody for 45 minutes at room
temperature. Slides were washed thrice in PBS for 5 minutes. Stained sections were examined
using a Leica TCS SP5 Confocal microscope (Leica Microsystems: North Ryde, NSW, Austra-
lia). Nuclear DNA was stained with DAPI (Sigma-Aldrich, St Louis, MO, USA). Antibodies
used were specific for CD11b (M1/70), CD11c (HL3), H-2Kk (36-7-5), CD150 (TC15-
Hematopoiesis in spleen
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12F12.2), CD41 (MWReg30) and CD48 (HM48-1) all purchased from Biolegend (San Diego,
CA, USA).
Flow cytometric analysis
Procedures for staining cells with antibodies for flow cytometric analysis of cell surface marker
expression have been described in detail previously [28, 31]. Briefly, cells were suspended in
buffer (DMEM with 0.1% sodium azide and 1% FCS) and then incubated with ‘Fc block’ spe-
cific for FcγII/IIIR (CD32/CD16) (eBiosciences: San Diego, CA, USA), prior to labeling with
multiple fluorochrome-conjugated antibodies used at minimal saturating concentrations.
Antibodies used were specific for: CD11c (N418), CD11b (M1/70) and MHC-II (AF6-120.1)
from eBiosciences; CD45.2 (104), F4/80 (C1:A3-1), B220 (RA3-6B2), CD3e (145-2C11),
Thy1.2 (30H-12), cKit (2B8), CD150 (TC15-12F12.2), CD48 (HM48-1), CD29 (HMß1-1),
gp38 (8.1.1), CD140a (APA5), VCAM-1 (429), CD105 (MJ7/18), CD51 (RMV-7), CD54
(YN1/1.7.4), CD31 (390), H-2Kk (36-7-5), MHC-II (25-9-17), Flt3 (A2F10), Sca1 (2B8),
CD45.1 (A20) from Biolegend. Multicolour flow cytometric analysis was performed on an
LSRII flow cytometer (Becton Dickinson: Franklin Lakes, NJ, USA) after addition of 1μg/ml
propidium iodide (PI) for flow cytometric discrimination of dead cells. The specificity of anti-
body binding was monitored through use of isotype matched control antibodies used to set
gates to delineate specific antibody binding. Splenic leukocytes were also used as a positive
control for binding of antibodies specific to hematopoietic cells.
Culture of MSC from bone marrow
Cultures enriched for MSCs were established according to published methods [32]. This
involved repeated medium change of cultured bone marrow cells followed by trypsinization to
provide cells for differentiation studies. To establish cultures, bone marrow was flushed from
the femur and tibiae of C57BL/6J mice using DMEM and filtered through a 70μm nylon mesh
filter. Red blood cells were removed by lysis with isotonic buffer (140mM NH4Cl, 17mM Tris
Base, pH7.5), and cells cultured at 107 cells/ml in sDMEM. After 24 hours, non-adherent cells
were removed by medium replacement, and cells then maintained by medium exchange every
3 to 4 days. After 14 to 18 days, cells were subcultured following treatment with 0.25% trypsin-
EDTA for 2 minutes at 37˚C and cells replated at a density of 105 cells/ml in preparation for
culture under conditions which stimulate osteogenesis, adipogenesis or chondrogenesis.
Osteogenic differentiation
Bone marrow cultures established at 105 cells/ml were cultured in a-MEM medium supple-
mented with 10% fetal calf serum, 5x10-4M 2-mercaptoethanol, 10mM HEPES, 100U/ml peni-
cillin and 100ug/ml streptomycin (Sigma-Aldrich). To induce osteogenesis, medium was
supplemented with 10-8M dexamethasone, 100uM ascorbic acid 2-phosphate and 10mM β-
glycerophosphate (all Sigma-Aldrich) [32, 33]. Cultures were maintained for up to 4 weeks.
Cells were not passaged over this time but medium was replaced every 3 days. Concurrently,
stromal lines were maintained at ~105 cells/ml in the same culture medium by passaging every
4 days throughout the differentiation period using 0.25% trypsin-EDTA to dissociate cells.
Parallel cultures of 5G3 and 3B5 were passaged in normal medium at the same density as an
undifferentiated control. Cells were harvested at several time points and stored at -80˚C for
later analysis of alkaline phosphatase activity and gene expression. After 21 and 23 days of cul-
ture in osteogenic medium, cells were washed twice with PBS, fixed with 70% ice-cold ethanol
for 1 hour at 20˚C and stained with 40mM Alizarin Red S (pH 4.1–4.3) for 10 minutes at 20˚C
[34]. Excess stain was removed with a distilled water wash and cells observed microscopically.
Hematopoiesis in spleen
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Adipogenic differentiation
To induce adipogenic differentiation, bone marrow cells were seeded at 105 cells/ml, cultured
as monolayers in sDMEM to attain confluency. They were then maintained in differentiation
medium composed of sDMEM supplemented with 10-6M dexamethasone (Sigma-Aldrich),
10ug/ml insulin (Becton Dickinson, Bedford, MA, USA), 0.45M 3-isobutyl-1-methylxanthine
(Sigma-Aldrich) and 0.2mM indomethacin (Sigma-Aldrich) [35–37]. After 3 days, medium
was replaced with adipogenic maintenance medium comprising sDMEM supplemented with
10μg/ml insulin for two days. After 14 to 16 days of adipogenic induction, cells were washed
twice with PBS, fixed with 10% neutral buffered formalin for 1 hour and stained with fresh Oil
Red O solution for 10 minutes to detect accumulation of cytoplasmic triglycerides. Excess
stain was removed with several distilled water washes and cells photographed by microscopy.
Stain was prepared by mixing three volumes of 0.5% Oil Red O powder (w/v) in isopropanol
with two volumes of distilled water. Bone marrow cultures were not passaged, but 5G3 and
3B5 cultures were passaged at medium change as described above for osteogenic differentia-
tion. Parallel cultures of 5G3 and 3B5 maintained in sDMEM medium served as undifferenti-
ated controls.
Chondrogenic differentiation
To induce chondrogenesis, cultured bone marrow cells were seeded at 105 cells/ml in serum-
free sDMEM supplemented with 10−7 dexamethasone, 0.35 mM L-proline, 100uM ascorbic
acid-2-phosphate (Sigma-Aldrich), ITS+ premix (6.25 ug/ml insulin, 6.25 ug/ml transferrin,
6.25 ng/ml selenious acid, 1.25 mg/ml bovine serum albumin and 5.35 ug/ml linolenic acid)
(Becton Dickinson) and 10 ng/ml TGF-β3 (R&D Systems: Minneapolis, MN, USA). Medium
was changed every 3 days with addition of TGF-ß3 and maintained for a period of 3 weeks [35,
36]. Bone marrow cultures were not passaged, but 5G3 and 3B5 cultures were passaged at
medium change as described above for osteogenic differentiation. Parallel cultures of 5G3 and
3B5 were maintained in sDMEM medium as undifferentiated controls. Cells were subjected to
Alcian Blue staining to confirm chondrogenic differentiation after 21 to 23 days. Cells were
washed twice with PBS, fixed with 10% neutral buffered formalin for 1 hour at 20˚C and
stained with 1% Alcian Blue solution (pH 2.5) for 20 minutes. Excess stain was removed with
several washes of distilled water and cells photographed microscopically to detect accumula-
tion of sulphated proteoglycans within the extracellular matrix of chondrocytes.
Alkaline phosphatase assay
To determine the expression of alkaline phosphatase by cells undergoing osteogenesis, the Sen-
soLyte alkaline phosphatase assay kit (Anaspec: Freemont, CA, USA) was used according to
the manufacturer’s instructions. Cell lysates from cultures undergoing induced osteogenesis
were prepared at days 0, 4, 8, 12, 16 and 20 days of culture and mixed with the p-nitrophenyl
phosphate substrate with incubation at 37˚C. The optical density of p-nitrophenol phosphate
was determined spectrophotometrically at 405nm. Alkaline phosphatase activity was calcu-
lated as μmoles/min/ng protein.
Quantitative RT-PCR
Cells cultured under osteogenic conditions were collected at 0, 8, 16 and 24 days. RNA was
extracted using the RNeasy mini kit (Qiagen: SABiosciences: Valencia, CA, USA) as per the
manufacturer’s instructions. The concentration and purity of RNA was determined spectro-
scopically. RNA was converted to cDNA using the RT2 First Strand Synthesis kit (Qiagen) as
Hematopoiesis in spleen
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per the manufacturer’s instructions. The resultant cDNA was then used as a template for
amplification by Real Time PCR. Primers used were purchased from SABioscience (Frederick,
MD, USA) specific for genes: Actb (beta-actin: PPM02945A), Bglap (bone gamma carboxyglu-
tamate protein/osteocalcin: PPM04465E), Alpl (Alkaline phosphatase: PPM03155A), Spp1
(secreted phosphoprotein 1/osteopontin: PPM03648C), Ibsp, (integrin binding sialoprotein/
bone sialoprotein: PPM35999A), and Sp7 (Sp7 transcription factor 7/osterix: PPM35999A).
The cDNA primers and RT2 SYBR Green Master mix were added to RNA in a ratio of
1:6.25:5.25, respectively, and samples plated in a 384 well plate and loaded on to a Light Cycler
480 (Roche: Castle Hill, NSW, Australia). Cycling conditions used were: 1 cycle for 10 minutes
at 95˚C to activate DNA Taq Polymerase, followed by 45 cycles of 15 sec at 95˚C for extension
and 1 minute at 60˚C to quantitate PCR products. Data analysis was performed initially using
Roche Light Cycler 480 software v1.2.9.11. B-actin was used a house-keeping control gene for
normalization. The absolute Quantification (2nd derivative max) method at high confidence
was used to obtain a CT value or threshold cycle. CT values were exported into Microsoft Excel
and the relative gene expression levels estimated using the 2-ΔΔCT method, taking gene expres-
sion at day 0 as reference.
Transcriptome analysis
Total RNA was isolated from stromal cell lines using the RNeasy mini kit and following the
manufacturer’s protocol (Qiagen), and the concentration and purity of RNA determined
spectrophotometrically. Double stranded cDNA was synthesized in a two-step process. The first
strand of cDNA was synthesised using T7-(dT)24 primers and Superscript II reverse transcrip-
tase (Invitrogen Life Technologies: Mount Waverley, VIC, Australia). This was followed by sec-
ond strand cDNA synthesis. Double-stranded DNA was then purified using phenol-chloroform
together with phase-lock gels (Brinkmann Instruments: Westbury, NY, USA). Subsequent pro-
cedures were performed by the Biomolecular Resources Facility (JCSMR, ANU). In vitro tran-
scription and biotin labeling were performed using the BioArray High Yield RNA Transcript
Labelling Kit (Affymetrix). cRNA was cleaned up on RNeasy Spin columns (Qiagen), frag-
mented, and then labeled with biotin. Fragmented and labelled cRNA was hybridized to Murine
Genome 430v2 genechips following the manufacturer’s procedures (Affymetrix: Santa Clara,
CA, USA). These were washed and stained on the fluidics station (Affymetrix) ahead of scan-
ning and image analysis using a Gene Array Scanner (Affymetrix). Comparative analysis across
two experiments (Expt 1: STX3, 2A8, 5G3, 3B5; Expt 2: 7G10, 5G3, 3B5) involved standardiza-
tion of genechips and removal of variation due to batch effect. Scanned images of genechips
were processed using Microarray Suite 5.0 software (MAS5.0; Affymetrix).
Analysis of microarray data
Gene expression data was analysed using Partek to give average signal values and p values by
Stephen Ohms (Biomolecular Resource Facility: ANU, Canberra, Australia). Microsoft Excel
files containing all information on probeset numbers, genes, signal values and p-values were
prepared for Principal Components Analysis. Data mining on the basis of average signal values
was used to determine gene expression associated with known functions or lineages. Heatmap
analysis and agglomerative hierarchial clustering using the Lance-Williams dissimilarity for-
mula involved the use of R project (http://www/r-project.org/).
Ectopic grafting
Two methods for graft preparation were employed. Due to the overall difficulty of the proce-
dure, outcomes of both procedures were taken as informative.
Hematopoiesis in spleen
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By the collagen sponge method: in vitro grown stromal cells were harvested by trypsiniza-
tion and filtered through a 70μm cell strainer to produce a single cell suspension. To prepare
each graft, ~1–2 x 106 cells were sedimented (1200 rpm, 4˚C, 5 minutes) and resuspended in
20ul sDMEM using a P20 pipette tip sealed at the opening with Parafilm (1200 rpm, 4˚C, 10
minutes). The cell pellet formed was then released on to a collagen sponge construct soaked in
400ul sDMEM and placed in one well of a 6-well plate for overnight incubation.
By the Matrigel method: in vitro grown stromal cells were harvested and filtered as
described above. Cells were then pelleted and resuspended in 10-20uL Matrigel (Matrigel
Matrix, standard formulation 8–12 mg/mL: Corning, New York, USA). The Matrigel-cell mix
was withdrawn into a 1-10uL Wiretol capillary micropipette (Drummond, Broomall, PA,
USA) and allowed to soldify at room temperature before injection.
Prior to grafting, NOD/SCID mice were anaesthetized with 3.5% isofluorane in oxygen. A
20-25mm skin incision was made in the region of the left kidney, the kidney was exteriorized
and a 2-4mm incision made in the capsule. Fine-tipped forceps were used to create a pocket
between the capsule and the underlying parenchyma into which the graft was implanted.
Upon completion, the kidney was replaced back into the body cavity and sutures and skin sta-
ples were used to close the incision wounds. The graft was dissected out from the renal capsule
at 1, 3 or 4 weeks post-grafting, and cut into smaller pieces before treatment with collagenase
to dissociate cells for analysis using antibody staining and flow cytometry. In some cases multi-
ple separated grafts were applied to the same kidney to increase the chance of engraftment. In
these animals, individual grafts were analysed independently.
Statistical analysis
Data are presented as mean ± standard error (SE) for sample size n. The Wilcoxon Rank Sum
test was used to assess significance (p� 0.05).
Results
Splenic stroma which support in vitro hematopoiesis reflect perivascular
reticular cells
In line with their splenic origin, stromal lines STX3, 5G3, 3B5, 7G10 and 2A8 (not shown) sup-
port myelopoiesis for an extended period when overlaid with splenocytes depleted of lymphoid
and erythroid cells. Fig 1A shows production of non-adherent cells out to 42 days, with 3B5
the poorest supporter. Co-cultures reveal loosely adherent cells over a confluent stromal
monolayer (Fig 1B). Three main cell types are produced out to 14 days: CD11b+CD11c- (mye-
loid cells), CD11b+CD11c+MHC-II+ (cDC-like cells) and CD11b+CD11c+MHC-II- (L-DC),
with the latter dominating out to 28 days (Fig 1B). The population of cDC-like cells has
recently been characterized as regulatory DC [38].This pattern of restricted hematopoiesis
with long-term production of the novel dendritic-like cell ‘L-DC’ has been demonstrated con-
sistently over time using bone marrow as a source of progenitors [19, 23, 39].
Further studies concentrated on 5G3 and 3B5, since these stromal lines were the best in
vitro growers making experimentation more feasible. Phenotypic analysis of the 5G3 and 3B5
stroma was used initially to determine relationship with endothelial, mesenchymal and peri-
vascular reticular cells, otherwise called CXCL12-abundant reticular (CAR) cells. Confluent
stroma was dissociated and stained with a range of antibodies. These cells showed no expres-
sion of markers of the hematopoietic lineage (Table 1). Stroma also lacked markers of mature
endothelial cells like CD31 and CD54. They did express markers common to mesenchymal
stem cell (MSCs) including CD105, CD29, CD106 (VCAM1), LY6A (Sca1) and CD90
Hematopoiesis in spleen
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(Thy1.2) [40–43]. Stroma reflect CAR cells with expression of markers like CD106, LY6A and
CD90 [44–48]. 3B5 and 5G3 are also reflective of stromal cells reported to support hematopoi-
esis in that they express CD51 and CD140A [44, 49]. Their resemblance with perivascular
reticular cells described in mouse, and CAR cells described in humans, was evident through
expression of CD51, VCAM1 and PDGFRA (CD140a) [44, 49, 50]. 5G3 and 3B5 also
expressed podoplanin (gp38), previously described as a marker of fibroblastic reticular cells in
spleen [51].
Analysis of stroma through gene expression analysis
In order to investigate the lineage origin of stromal lines, transcriptome analysis was per-
formed using Affymetrix Murine Genome 430v2 genechips. Two separate experiments were
performed comparing multiple stromal lines. Controls included hematopoietic cells isolated
from long-term stroma-dependent cultures of spleen which produce myeloid and dendritic-
like cells (LTC-DCs). The first analysis looked at the relationship between the stromal cell lines
under the hypothesis that 3B5 is distinct from other lines in terms of lineage origin since 3B5
cells are superior in vitro supporters of hematopoiesis. Only small differences in overall gene
expression between the stromal lines were indicated through Principal Component Analysis
Fig 1. Stromal co-cultures support hematopoiesis. Co-cultures were established in triplicate by overlay of T and B
cell depleted splenocytes at 0.5–1 x 105 cells/ml over near-confluent stroma. Controls comprised stroma alone and ‘T/B
depleted splenocytes’. (A) Co-cultures were established with 3B5, 5G3, 7G10 and STX3 stroma. Non-adherent cells
were collected at 7-day intervals for estimation of percent (%) live cell recovery relative to input cell number using
trypan blue exclusion for cell counting. Data represent mean ± standard error (n = 3). Cell production by 3B5
compared with all other stroma was statistically significant at each time point (p�0.05). (B) Co-cultures were
established over 5G3 stroma. Cell production was compared and photographed at 14 and 28 days under brightfield
(Objective 20x, bar 250μm). Non-adherent cells were collected and stained with antibodies specific for CD11c, CD11b
and MHC-II, or with isotype controls to set gates. Propidium iodide (PI) staining prior to flow cytometry allowed
gating of PI- (live) cells and FSC and SSC analysis was used to gate large (FSChi) cells for subsequent analysis. Numbers
shown in quadrants represent percent positive cells. Culture of stroma alone have no cell production (not shown).
https://doi.org/10.1371/journal.pone.0223416.g001
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(PCA). Greatest variability in gene expression was seen for the first and second principal com-
ponents, where greatest variability was encountered (29.3% and 24%, respectively) (Fig 2A).
3B5 was distinguished from other stromal lines in the first principal component. Hierarchical
clustering was used to identify the relationship between stromal lines on the basis of gene
expression. This also confirmed some distinction between 3B5 and all other stroma (Fig 2B).
Small differences between the same cell line analysed in different experiments are most likely
due to natural variation developing in cell lines following in vitro culture. Since all lines
derived from the long-term cultured line STX3, it is expected that the variation seen between
cloned lines is not due to intrinsic differences between distinct stromal. Despite their value as a
model for study, long-term cultured cell lines will not accurately reflect in vivo biology.
Data mining was used to investigate the expression of genes reflecting distinct stromal cell
types. This involved retrieval of signal values for sets of genes related to the lineage origin and
function of MSCs, osteoblastic cells, endothelial cells including lymphatic endothelial cells and
perivascular reticular cells. The gene sets used were collated from the literature with lineage-
specific genes selected where possible [52–57]. Fig 2C shows a heat map detailing signal value
for selected genes. Very similar gene expression was obtained for each of the 5G3, 2A8, 3B5
and STX3 stroma, suggesting a common lineage origin. Hematopoietic cells produced in LTC
(LTC-DCs) served as controls, showing distinct gene expression.
Table 1. Cell surface markers expressed by stroma.
Cell surface marker Cell type specificity a,b MFI - 5G3 c MFI - 3B5 c
Stromal cells
gp38 FRC 6720 ± 839 4110± 814
CD105 MSC, CA, RPS 493 ± 80.9 464 ± 140
CD29 MSC, FRC 2070 ± 243 2520 ± 450
CD90 (Thy1.2) MSC, CAR cells 6730 ± 457 2640 ± 446
CD51 CAR cells 294 ± 51.0 299 ± 94.5
LY6A (Sca-1) MSC, CAR cells 3160 ± 579 279 ± 83.3
CD106 (VCAM1) MSC, CAR cells, FRC, MRC 448 ± 47.3 179 ± 29.5
CD140a (PDGFRA) CAR cells, CA, RPS 403 ± 160 123 ± 48.9
CD31 EC 13 13
CD54 (ICAM-1) EC 9 7
Hematopoietic cells d
CD3e T cell 0 0
B220 B cell 2 4
CD150 Hematopoietic cells 2 0
CD48 Hematopoietic cells 6 1
CD11b Myeloid cells 1 0
MHC II Antigen presenting cells 71 28
F4/80 Macrophages 0 1
CD11c Dendritic cells 0 2
Ly6G Neutrophils 5 6
CD45.2 Hematopoietic cells 36 36
a CAR cells, CA, central arteriole; CXCL12-abundant reticular cells; EC, endothelial cells; FRC, fibroblastic reticular cells; MRC, marginal zone reticular cells; MSC,
mesenchymal stem cells; RPS, red pulp sinusoids.
b Mueller and Germain 2009 [43]; Nagasawa et al. 2011 [42]; Oh and Kwon 2010 [40]; Omatsu et al. 2010 [36]; Pinho et al, 2013 [41].
c Mean fluorescence intensity (MFI), shown as mean ± SE (n = 4) for expressed markers.
d Splenic leukocytes were stained as a positive control for hematopoietic markers. Stainings were not duplicated due to the use of overlapping lineage markers.
https://doi.org/10.1371/journal.pone.0223416.t001
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None of the stromal lines expressed genes encoding markers specific for endothelial cells
like the Vegfr family, Cd144 (VE-Cadherin), Cd62p (P-selectin), Cd54 (ICAM-1), Cd31
(PECAM-1), Tie1 (angiopoietin receptor), Vwf (von Willebrand Factor), Cd62e (E-selectin),
or Cd143 (Ace) (Fig 2C). 3B5 did weakly express Cd34, which encodes a marker of hematopoi-
etic progenitors and MSCs It is also expressed by vascular endothelial cells [58] (Fig 2C) and
by a subset of pericytes [59]. Cd34 expression however is thought to vary with culture and so
may not be a reliable marker of lineage [60]. None of the lines expressed the most common
marker of mature lymphatic endothelial cells Lyve-1, nor the Prox1 transcription factor [61].
All stromal lines expressed genes related to osteogenesis including Spp1 (osteopontin) required
for osteoblast differentiation, Col1a2 (bone specific collagen) and Mmp2 (matrix metallopro-
teinase 2) involved in bone and cartilage formation (Fig 2C). Stroma also expressed Fn1 (fibro-
nectin), Cdh11 (cadherin 11) and Bmp2 (bone morphogenetic protein 2), all indicative of
osteogenic development. Stroma did not express transcription factors essential for osteoblast
differentiation including Cbfa1 and Sp7 (osterix), nor did they express genes reflecting mature
Fig 2. Gene profiling identifies splenic stromal lines as mesenchymal cells. Transcriptome analysis using Affymetrix
Murine Genome 430v2 genechips was performed on multiple stromal cell lines in duplicate experiments. Genechips
from two experiments were standardized and compared with control hematopoietic cells collected from long-term
spleen cultures (LTC-1, LTC-2). (A) Principal Component Analysis (PCA) was used to determine variability in gene
expression for each sample. Shown are first (PC#1) and second (PC#2) principal components. (B) Hierarchial
clustering was used to analyze the relationship between stromal lines on the basis of gene expression. The dendrogram
displays distance between subsets based on clustering 5077 genes selected for analysis on the basis of mean signal
value> 1000 for any one stromal line. (C) Data mining was used to plot signal value for genes identified as specific for
lymphatic endothelial cells (LEC), endothelial cells (ENDO), osteogenic cells (OSTEO), mesenchymal stem cells
(MSC) and perivascular reticular cells (PVRC).
https://doi.org/10.1371/journal.pone.0223416.g002
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osteoblasts like Alpl (alkaline phosphatase), Bglap2 (osteocalcin) and Ibsp (bone sialoprotein).
Stroma expressed Col1a1 (collagen type1 alpha 1), Sca-1 (Ly6A), Cd164 (sialomucin), Cd90
(THY1), Cd29 (integrin b1), Cd106 (VCAM1) and low levels of Cd105 (endoglin), all reflecting
a relationship with mesenchymal stem/progenitor cells and confirming data shown in Table 1.
The stromal lines did not however express Cd166, Cd14, cKit, Cd73 and Cd13, reported as
markers of mesenchymal cells [62]. The absence of KitL (SCF) expression distinguishes these
stroma from endothelial cells, and subsets of perivascular reticular cells identified in bone mar-
row which produce both CXCL12 and SCF [63], but aligns them with cells in spleen which
have been identified as HSC niches elements [7]. However, all cell lines expressed gp38,
expressed by mesenchymal stromal cells in spleen [51].
Stroma also expressed genes consistent with described perivascular reticular subsets found
in bone marrow and spleen including high expression of Cxcl12 and low expression of KitL
(SCF) which encode known regulators of hematopoiesis [63]. Expression of genes like Mmp3,
Cd106, Cd51 and Pdgfrb are also characteristic of CAR cells [53] and are expressed by each of
the stromal cell lines. Pdgfra expression was lower than Pdgfrb expression, with cell surface
marker expression (CD140a) also detectable in Table 1. Expression of Nkx2-5 was consistent
with the mesenchymal lineage origin of cells [64]. Stromal lines were however distinct from
bone marrow perivascular reticular subsets which express Nes, Mcam, Ng2, Lepr and Nte5
[65]. In summary, 5G3, 3B5, 2A8, 7G10 and STX3 all show characteristics of mesenchymal,
osteogenic cells resembling perivascular reticular cells, with no evidence for expression of
genes reflective of endothelial or hematopoietic cells. Stromal cells were clearly distinct from
myeloid cells produced in LTC (LTC-DC) which strongly express Spp1, Cd164 and Cd14 [12]
(Fig 2C).
Further evidence of the similarity between the stromal lines comes from common cytokine
and chemokine gene expression. Supplementary Fig 1E shows Log2 signal values attained by
transcriptome analysis for chemokine and cytokine pathway genes selected by SASBiosciences
for their PCR arrays. Overall expression appears to be constant across the stromal lines but with
a few clear differences. All cell lines expressed very high levels of Ccl8, Mmp2, Cxcl12, Ccl2, Ccl7,
Cxcl5, Cxcl10, Csf1, Cxcl1 and Ccl5, reflective of common functionality in hematopoiesis (S1
Fig). CXCL12 expression is common to perivascular reticular cells in bone marrow, while CSF1
is a myeloid differentiation factor. Notable are the higher expression of IL-6 and Cxcr7 by 3B5
over all other lines. IL-6 is an important regulator of inflammation, while CXCR7 is a chemo-
kine receptor which binds CXCL12. Since CXCL12 binding to CXCR4 on HSC is an important
regulator of HSC migration and hematopoiesis [45], CXCR7/CXCL12 binding could negatively
impact the potential of 3B5 to support in vitro hematopoiesis, and this has been reported previ-
ously for a stromal cell line MS-5 overexpressing CXCR7 [66]. The stromal cell lines did not
express many cytokine genes, although Mif was most highly expressed. 3B5 did noticeably upre-
gulate Lif and showed downregulation of Il-16 and Il-7 compared with other stroma (S1 Fig).
LIF (leukemia inhibitory factor) inhibits differentiation of stem cells and could be an important
factor in the inability of 3B5 to support in vitro hematopoiesis.
Splenic stromal lines have osteogenic potential
As a further test of the mesenchymal stem/progenitor phenotype of stromal lines, attempts were
made to induce differentiation of 5G3 and 3B5 stroma towards osteogenesis, adipogenesis and
chondrogenesis using defined culture conditions. MSCs cultured out of bone marrow were
used as controls. By necessity, stromal lines had to be passaged regularly over the experiment to
reduce numbers of cells. To measure osteogenesis, cells were cultured under mineralization
conditions for a period of 21 days, and then stained with Alizarin Red S to detect osteogenesis
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based on calcium deposits within the mineralized extracellular matrix [36]. Treated 5G3 and
3B5 stromal lines stained positively after 21 days in comparison with untreated stroma,
although staining was moderate in relation to cultured bone marrow cells (Fig 3A).
Stromal cell lines were also cultured under adipogenic conditions, and Oil Red O stain
used to assess differentiation after 14 days (Fig 3B). Neither 5G3 nor 3B5 cells showed stain-
ing, while cultured bone marrow MSCs showed multiple intracellular lipid droplets accu-
mulating Oil Red O. By 14 days, cultured bone marrow cells developed a mature adipocyte
morphology, while no morphological changes were observed in 3B5 or 5G3 cells. Capacity
to undergo chondrogenesis was assessed through production of chondrocytes which aggre-
gate and mature, producing extracellular matrix containing aggregated proteoglycans
which stain with Alcian Blue. Under these conditions, 5G3 and 3B5 showed no significant
change in morphology out to 21 days, and no specific staining with Alcian Blue (Fig 3C). In
control cultures of MSC, sulphated mucopolysaccharides characteristic of the extracellular
matrix of chondroblasts accumulated Alcian Blue stain, indicating mature cells (Fig 3C).
Fig 3. Splenic stromal lines reflect osteoprogenitors. The 5G3 and 3B5 stromal cell lines were cultured under
different conditions to induce osteogenic, adipogenic and chondrogenic differentiation, with medium replacement
every 3 days. Controls were cultured under normal conditions. In parallel, bone marrow derived MSCs were induced
to differentiate under the same growth regime. (A) Cells were cultured for 21 days under mineralization conditions to
induce osteogenesis, and then stained after 21 days with Alizarin Red S stain. (B) Cells were cultured for 21 days under
chondrogenic conditions and then stained with Alcian Blue. (C) Cells were cultured for 14 days under adipogenic
conditions and then stained with Oil Red O. Cells were photographed under bright field microscopy. Unstained cells
were photographed under phase. Bar represents 100μm. Data reflect a representative result from replicated
experiments.
https://doi.org/10.1371/journal.pone.0223416.g003
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Controls showed round cell morphology and formed small cell aggregates after 14 days.
5G3 showed some extracellular fibrous material across the cell monolayer, perhaps indica-
tive of a low level of chondrogenesis. While 5G3 and 3B5 cells were grown as monolayers,
there was no evidence of cellular aggregation although cells became more flattened and
acquired a more cuboidal phenotype (Fig 3C).
Alkaline phosphatase production is an early marker of osteoblast differentiation [67, 68].
Enzyme activity was detected in supernatants of 5G3, 3B5 and bone marrow derived MSCs
cultured under mineralization conditions using the SensoLyte assay. 5G3 and 3B5 cultured in
normal medium served as controls. Alkaline phosphatase was first detected after 4 days in all
cultures and increased until 16 days (Fig 4A). Levels detected in bone marrow cultures were
up to 10-fold higher than for stromal lines. For cells grown under osteogenic conditions, these
values were significantly higher than Day 0 levels after Day 8 (p�0.05).
Fig 4. Stromal cells reflect osteogenic progenitors. The 5G3 and 3B5 stromal cell lines were cultured under
osteogenic conditions (closed symbols), and under normal growth conditions as a control (open symbols). Duplicate
experiments are shown by different symbols, and data points represent mean ˚ SE of three experimental replicates.
Comparison was made with bone marrow-derived mesenchymal cells cultured in parallel under osteogenic conditions.
(A) Alkaline phosphatase production (expressed as micromoles/min/ng) was assessed over time using the SensoLyte
alkaline phosphatase assay. Day 8, 16 and 24 levels are significantly different from Day 0 values for all samples cultures
under osteogenic conditions (p�0.05). (B) Quantitative RT-PCR was used to measure change in gene expression over
time for genes encoding alkaline phosphatase (ALPL), osterix (OSX), osteocalcin (OC), bone sialoprotein (BSP) and
osteopontin (OPN). Data are shown as fold change in gene expression at 8-day intervals relative to Day 0 gene
expression. For samples cultured under osteogenic conditions, gene expression was significantly different (p�0.05)
from Day 0 levels by Day 16, except for the osteocalcin (OC) by Day 24. Untreated samples showed no significant
increase above Day 0 levels.
https://doi.org/10.1371/journal.pone.0223416.g004
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To further confirm that the 5G3 and 3B5 stromal lines differentiate to give mature osteo-
blastic cells, quantitative RT-PCR was used to measure expression of genes related to osteogen-
esis across 24-day cultures. Genes monitored included Alpl which encodes alkaline
phosphatase, Spp1 which encodes osteopontin and Sp7 encoding osterix as markers of early
osteogenic differentiation, with Bglap2 encoding osteocalcin and Ibsp encoding bone sialopro-
tein as late markers of mineralization associated with osteoblast formation [67, 69]. Over 24
days of culture under mineralization conditions, the expression of genes of interest in cultured
bone marrow derived MSCs increased 12- to 24-fold, and by 4- to 6-fold above base levels for
5G3 and 3B5 (Fig 4B). For most genes, expression reached peak levels by 16 or 24 days of cul-
ture consistent with changes detected in bone marrow MSCs. Significant increases in gene
expression were detected by Day 16 for all genes, but by Day 24 for Bglap2 encoding Osteocal-
cin (OC) (p�0.05) (Fig 4B). Untreated samples showed no significant change above Day 0 lev-
els across the 24 day culture. These changes involved genes reflecting both early and late
osteogenesis, although changes were smaller than for bone marrow derived MSCs (Fig 4B).
Alkaline phosphatase mRNA expression reached a peak at Day 16 of culture in agreement
with enzyme activity measured in parallel experiments (Fig 4). Data from a repeat experiment
is shown in S2 Fig.
Splenic stroma forms ectopic niches which support hematopoiesis
Splenic stromal cell lines studied here were then tested for capacity to form ectopic hematopoi-
etic niches in vivo following transplantation into the subcapsular region of adult NOD/SCID
mouse kidney. Initial grafting involved the 3B5 and 5G3 lines, with later testing of 10C9, STX3
and 7G10 stromal lines. The different lines showed variable success in graft uptake. Grafting
with 3B5 had an overall 70% success rate, but 5G3 gave only 9.1% success rate (S1 Table). Fur-
ther experiments showed no success for STX3 and 7G10, with 60% success rate for 10C9.
These data suggest variable in vivo growth capacity amongst the lines. These differences did
not relate to time of cell lines in culture since lines were maintained as frozen stocks estab-
lished after only 4 or 5 passages and were grown for only 4 to 5 passages ahead of each experi-
ment. Since these are continuous cell lines of similar stromal cells, variability could relate to
variability in the transformation process individual to each line.
Grafting 3B5 stroma was very successful, particularly using the collagen sponge method,
and section staining at 4 weeks identified prolific stromal cell growth based on staining for
MHC-CI (H-2Kk) (Fig 5A). Successful grafts also contained mature host type myeloid and/or
dendritic cells detected by staining for CD11b and CD11c. Due to the small number of cells
recovered from grafts, antibodies used to stain myeloid cells were specific for only CD11c,
CD11b and F4/80, which is the minimum cocktail needed to distinguish L-DC from mono-
cytes/macrophages and cDC subsets [10]. Flow cytometry identified very consistent myeloid
cell types amongst the hematopoietic (CD45+) population present in 3B5 grafts (Fig 5B). Many
cells in the graft were mature CD11b+ and/or CD11c+ myeloid cells, with a major population
of CD11b-CD11c-cells reflecting hematopoietic progenitors/precursors. The CD11b-CD11c-
population contained no CD3+ or CD19+ cells reflective of T and B lymphocytes in line with a
NOD/SCID host origin, showing no infiltration of grafts by mature lymphocytes. Data for
myeloid subset representation were collected across multiple grafts (n = 9) (Table 2 and Fig
5B). 3B5 stromal grafts support the presence of a majority (34.4%) population of L-DC with a
CD11b+CD11cloF4/80+ phenotype. The next highest population comprised cells reflective of
monocytes/macrophages as CD11b+CD11c-F4/80+ cells (12.5%). A minor 3% population of
CD11b-CD11c+F4/80- plasmacytoid (p)DCs was identified, along with a 1.4% population of
CD8+ cDCs as CD11b-CD11c+F4/80+ cells, and a 3.2% population of CD11b+CD11chiF4/80+
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CD8- cDCs. No B cells (CD19+) or T cells (CD3+) were detected as expected for NOD/SCID
mice as hosts (Table 2). As with 3B5 grafts, 10C9 grafts comprised a majority population of
CD11b+CD11cloF4/80+ cells reflecting L-DC (S3 Fig). The 3B5 and 10C9 grafts showed almost
Fig 5. Development of ectopic hematopoietic tissue through grafting of 3B5 stroma. 3B5 stromal cells were grown
on a collagen sponge ahead of transplantation under the kidney capsule of NOD/SCID (CD45.1) mice. Grafts were
dissected out after 4 weeks and cells dissociated for antibody staining and flow cytometry. (A) Myeloid cells were
localized in grafts through staining frozen sections using antibodies specific for CD11b and CD11c along with H-2Kk
which is specific for donor and not host type cells. Bar represents 25um. (B) Live singlets were gated and staining with
CD11b, CD11c and the F4/80 marker was used to identify myeloid subsets. Staining for CD3 and CD19 expression on
the gated CD11b-CD11c- population was used to identify lymphoid cells. Three grafts from individual mice were
analysed and cell composition compared with spleen leukocytes from adult C57BL/6J and NOD/SCID mice.
https://doi.org/10.1371/journal.pone.0223416.g005
Table 2. Representation of hematopoietic cells within 3B5 grafts.
Subset identified a Predicted cell type % cells within graft b
CD11b-CD11c-F4/80-CD3+CD19- T cell 0.02 ± 0.01
CD11b-CD11c-F4/80-CD3-CD19+ B cell 0.00 ± 0.00
CD11b+CD11cloF4/80+CD3-CD19- L-DC 34.41 ± 8.14
CD11b+CD11c-F4/80+CD3-CD19- Monocyte/macrophage 12.45 ± 4.15
CD11b-CD11c+F4/80-CD3—CD19- Plasmacytoid DC 2.96 ± 0.98
CD11b-CD11c+F4/80+CD3-CD19- CD8+ cDC 1.36 ± 0.45
CD11b+CD11chiF4/80+CD3-CD19- CD8- cDC 3.21 ± 1.07
a 3B5 stromal cells were grown on a collagen sponge and transplanted under the kidney capsule of NOD/SCID (CD45.1) mice. Grafts were dissected out after 4 weeks
and cells dissociated for analysis by antibody staining and flow cytometry. Subsets were identified by expressed markers only. The unidentified cells in the graft reflect
hematopoietic precursors and non-hematopoietic (stromal) cells as verified in Fig 5.
b Data reflect mean ˚ SE (n = 9). Analysis involved individual grafted mice.
https://doi.org/10.1371/journal.pone.0223416.t002
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no evidence of CD11b+CD11c+F4/80- cells (Fig 5B), a population which would contain eosino-
phils and neutrophils [10]. This result is consistent with the non-inflammatory environment
of these grafts. The presence of many hematopoietic precursors is also consistent with the graft
representing a supportive environment for the steady-state development of myeloid cells.
Grafting 5G3 stroma was much less successful than 3B5, contrasting with the superior abil-
ity of 5G3 over 3B5 to support in vitro hematopoiesis seen in Fig 1A. This finding also con-
trasts with the excellent in vitro growth capacity of both stromal lines. The cell composition of
each of three separate grafts of 5G3 made into one mouse is shown in S4 Fig. Grafts clearly
contain a small population of CD11b+ cells, possibly reflecting two subsets. The absence of
CD11b-CD11c- cells reflecting early lymphocytes and myeloid precursors was notable in com-
parison with 3B5 (Fig 5) and 10C9 grafts (S3 Fig). Some CD11b+ cells expressed F4/80 suggest-
ing the presence of either L-DCs or cDCs, but others were F4/80- consistent with the presence
of neutrophils or eosinophils and reflective of an inflammatory environment. Overall, the cell
composition of 5G3 grafts was unusual compared with grafts comprising 3B5 and 10C9
stroma, in that CD11b-CD11c- precursor cells comprised only 3–13% of cells in the graft, com-
pared with ~60% for 3B5 and 10C9 grafts. This distinct composition was also consistent with
the low success rate of grafting for 5G3 stroma.
Ectopic stromal grafts maintain HSCs
An important question is whether mature myeloid and dendritic cells detected in grafts
develop in situ from colonizing progenitors, or from mature cells migrating into the grafts.
This was addressed by immunohistochemical and flow cytometric staining to detect hemato-
poietic stem/progenitor cells colonizing 3B5 grafts. A successful graft of 3B5 stroma under the
kidney capsule is shown in Fig 6A. Tissue fragments were isolated, and collagenase treated for
flow cytometric analysis. Staining identified HSCs as a Lin-Sca1+cKit+CD150+Flt3- subset of
long-term reconstituting HSCs [70] amongst the dissociated graft cells (Fig 6B). This suggested
that HSCs had infiltrated two distinct 3B5 grafts on two different animals and could be
detected through antibody staining. Section staining also identified hematopoietic stem/pro-
genitor cells as Lin-CD150+CD41-CD48- cells [6] scattered throughout the grafts, along with
some mature cells expressing Lin and/or CD41/48 markers (Fig 6C).
Discussion
Splenic stromal cell lines described here reflect mesenchymal perivascular and perisinusoidal
reticular cells previously characterized as a heterogeneous population in bone marrow express-
ing PDGFRA/B, SCF and CXCL12 [71]. Stromal subset isolation and analysis reflects a difficult
study, so that the availability of cell lines represents a rare opportunity to study stromal cell
characteristics and function. Evidence presented here also supports a role for splenic stromal
cells in formation of an ectopic in vivo niche for hematopoiesis giving rise to specific subsets of
myeloid cells. This finding has clear clinical importance in terms of expansion of hematopoi-
etic niches outside of the bone environment.
This study was initiated to investigate the lineage origin of stromal cell lines which were
known supporters and non-supporters of in vitro hematopoiesis. A main question was whether
supporters and non-supporters reflected different stromal subsets or even different cell line-
ages. However, all stromal lines studied were shown to have very similar gene expression pro-
files reflecting their lineage origin as mesenchymal, osteogenic perivascular cells. PCA analysis
confirmed small differences between cell lines, particularly separating 3B5 non-supporters
from other supporter lines. In the main, these differences would relate to variation due to
genetic and developmental changes following long-term in vitro culture than to any differences
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in cell lineage origin. For 3B5 and 5G3, this is confirmed in that both cell lines retain capacity
to differentiate to give osteogenic cells but did not undergo adipogenesis or chondrogenesis.
Gene expression changes over the course of mineralization cultures indicate that 5G3 and
3B5 represent cell line models of osteoprogenitors derived from spleen. Cells of the osteoblastic
lineage have long been known to be important regulators of hematopoiesis, but most of this
evidence relates to hematopoiesis in bone marrow, and the important role of osteoblasts on
the endosteum as a niche for primitive HSCs [48]. That hematopoiesis in bone marrow is
dependent on osteoprogenitors has been shown in various conditional deletion murine models
Fig 6. Detection of hematopoietic stem/progenitor cells in ectopic grafts. (A) Grafts of 3B5 stroma were prepared as
described in Fig 5. (B) Grafts were dissociated and analysed flow cytometrically to distinguish hematopoietic cells of
NOD/SCID host origin (CD45.1). Non-hematopoietic (including 3B5 stromal cells) were gated or excluded from
analysis. Hematopoietic stem/progenitor cells were then identified as the lineage-negative (Lin-) subset. Further
staining for stem cell markers cKit, Sca1, CD150 and Flt3 was used to identify HSCs in the graft as
Lin-cKit+Sca1+CD150+Flt3- cells. (C) Frozen sections from two separate grafts were stained for CD150 (red) and Lin/
CD41/CD48 (green). Arrows identify HSPCs as Lin-CD41/48-CD150+ cells. Bar represents 25um.
https://doi.org/10.1371/journal.pone.0223416.g006
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such as deletion of Cxcl12 in osterix-expressing osteoprogenitors which increased HSCs exit
from quiescence and entry into cell cycle, followed by mobilization into blood and spleen [72].
To some extent it is an enigma to find osteoprogenitors in spleen, although there is now
increasing evidence that perivascular reticular cells in multiple organs show osteoprogenitor
characteristics. This raises the question of whether osteogenic potential, and some level of oste-
ogenesis, is a feature of perivascular and perisinusoidal reticular cells developing in spleen, and
consistent with their potential to act as niches for HSCs.
Most work to date involving splenic stroma has involved in vitro analyses, so that evidence
for capacity to produce an ectopic niche in vivo is a very new finding which gives promise of
translational studies going forward. In order to optimize transplantation outcome, two proce-
dures were used, and both were successful. Cells were either cultured briefly above collagen
sponges, or mixed with Matrigel, an extracellular matrix comprising laminin, enactin, and colla-
gen IV [73–75]. Earlier studies involving neonatal spleen capsule grafts showed enlargement of
lymphoid follicles for up to 4 weeks post-transplantation [76]. Consistent with that study, 4
weeks post-transplantation was used as a reference point for graft examination and analysis,
although analyses at 1 and 3 weeks were also performed to assess outcomes. Previously, Tan
et al [76, 77] showed capacity to engraft murine spleen fragments and capsular tissue under the
kidney capsule with full development of splenic architecture and inclusion of hematopoietic
cells. Those studies also showed that dissociated stromal cells of 3-day spleen enriched for a sin-
gle marker, either CD31, CD105, CD201 or MadCAM-1, grew to form a successful graft. While
those studies led to regeneration of spleen architecture in grafts with formation of red and white
pulp regions filled with erythrocytes, lymphocytes and myeloid cells, the grafts formed here
with stromal cell lines reflecting perivascular cells do not lead to complete tissue reformation.
They do however function appropriately as a niche and support the uptake of HSCs and the
development of myeloid cell types of limited range reflecting the myeloid and dendritic-like
cells which are produced when stromal lines support restricted hematopoiesis in vitro.
Prior to engraftment of cell lines, multiple grafting studies were attempted in this lab
involving freshly sorted splenic stromal subsets sorted on the basis of multiple markers. These
experiments were very challenging due to the low number of stromal cells which were isolated.
So far, these studies have largely been unsuccessful. Our conclusion from these studies is that
stromal subsets isolated from spleen on the basis of multiple markers appear to reflect mature
cells which do not replicate well in vivo. Only less well-defined fractions are likely to contain
progenitors or spleen organizer cells which can lead to tissue regeneration. Grafting of stromal
cell lines here has been more successful, perhaps due to the transformed and proliferative
nature of cultured cell lines. The high success achieved with 3B5 stroma over other stromal
lines could relate to a more immature phenotype, and capacity to differentiate on engraftment.
The finding that 3B5 (and 10C9) stromal grafts became infiltrated with hematopoietic cells
with clear evidence of CD11b+CD11cloF4/80+ L-DC-like cells (Figs 5 and S3) contrasts with
evidence that 3B5 stroma is a weak supporter of myelopoiesis in vitro [19]. Here we show that
3B5 stroma functions as an in vivo niche which supports myelopoiesis leading to a range of
mature myeloid cells. Indeed, it would appear that these cells develop from bone marrow-
derived HSCs which infiltrate the graft, are maintained within the graft, and then differentiate
in situ. It is also likely that HSCs preferentially differentiate to give L-DC when influenced by
the microenvironment created by 3B5 stroma as was demonstrated in vitro [27], and that
other bone marrow precursors may colonize grafts for their further development. Preferential
differentiation of HSCs into L-DCs could account for the high proportion of L-DCs over other
monocytes/macrophages and DC subsets within the graft (Table 2).
Numerous in vitro studies involving co-cultures of splenic stromal lines with bone marrow-
derived hematopoietic stem/progenitor cells have identified production of the L-DC subset
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which is phenotypically and functionally distinct from all known DC and myeloid subsets
described [13, 17, 24, 28]. The physiological relevance of the L-DC subset is supported by evi-
dence for an in vivo equivalent subset in murine and human spleen which is not found to be
present in other tissue sites [10, 11, 78]. Recent investigation now shows L-DCs to be distin-
guishable both phenotypically and functionally from all splenic cDC and plasmacytoid (p)DC
subsets, and from residential and inflammatory monocytes [10]. We have also shown that
L-DC production in Booreana (c-MybE308) mutant mice occurs independently of c-Myb, a
gene known to regulate hematopoiesis from bone marrow-derived progenitors [79], consistent
with L-DC development directly from HSCs present in spleen without formation of a myeloid
progenitor. This is consistent with the previously published evidence that L-DCs develop
directly from HSCs and MPPs in stromal co-cultures in vitro [13, 24]. The hypothesis that
L-DCs derive from yolk sac-derived HSC laid down during development of spleen as reported
for other myeloid cells [80] can also be considered. There is a precedent for this proposal since
tissue-specific antigen presenting cells have been described in sites like skin and brain [81, 82].
L-DCs are not only spleen-specific but also unique as antigen presenting cells, in that they acti-
vate only CD8+ and not CD4+ T cells [83].
Spleen plays a major role in myelopoiesis and it has long been known to support the matu-
ration of myeloid precursors which traffick from bone marrow, the development of cDC from
their precursors and the maturation and mobilization of monocytes in response to tissue
injury. Now evidence is presented here that spleen contains stromal cell types which can func-
tion as a niche for hematopoietic stem and progenitor cells supporting the restricted develop-
ment of several myeloid cell types. The production ‘L-DC’, and of cDC-like DC resembling
regulatory DC, has already been reported in vitro and is now confirmed in an in vivo model.
This study identifies spleen as a competent site to support myelopoiesis and may act as a reser-
voir for hematopoietic stem and progenitor cells.
The findings presented here have direct relevance to the clinical importance of spleen as an
alternative site for hematopoiesis, particularly with loss of bone marrow niches for HSC which
occurs with ageing and disease. Spleen is a highly regenerative organ and the stromal cell types
which regenerate full tissue development include both endothelial and mesenchymal cell sub-
sets [77, 84]. This study specifically identifies a mesenchymal cell type, which if proliferating,
will form ectopic tissue which directs hematopoiesis and specifically myelopoiesis. This study
therefore identifies the minimal needs for production of artificial niches in vivo. The transla-
tional relevance of these findings relates to the ability to harness spleen as an alternate or
ectopic site for hematopoiesis so opening new opportunity for therapy in patients with bone
marrow disease, or other disease leading to immune system failure.
Supporting information
S1 Fig. Expression of pathway specific genes by stromal lines. Data mining was applied to
Affymetrix datasets collected for stromal cells. Log2 average signal value was plotted as a heat
map, and overlaid dashed blue line represents signal changes around mean). Sets of genes
reflecting chemokine, and cytokine pathways represent genes utilized by SASBioscience for
their PCR arrays.
(PDF)
S2 Fig. Osteogenesis in stromal lines marked by gene expression. A repeat experiment was
performed to assess expression of genes reflecting osteogenesis upon culture of 5G3 and 3B5
stroma under mineralization conditions. Quantitative RT-PCR was used to measure change in
gene expression over time in culture for genes encoding alkaline phosphatase (ALPL), osterix
(OSX), osteocalcin (OC), bone sialoprotein (BSP) and osteopontin (OPN) by 5G3 and 3B5
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stromal cells induced to undergo osteogenic differentiation (closed symbols). 5G3 and 3B5
grown under normal culture conditions served as control cells (open symbols). Data are
shown as fold change in gene expression at 8-day intervals relative to Day 0 gene expression.
Data points represent mean ˚ SE of three experimental replicates.
(PDF)
S3 Fig. Identification of hematopoietic cells in 10C9 ectopic stromal grafts. 10C9 stromal
cells were grown on a collagen sponge ahead of transplantation under the kidney capsule of
NOD/SCID (CD45.1) mice. Grafts were dissected out after 4 weeks and cells dissociated for
antibody staining and flow cytometry. Live singlets were gated and staining for CD11b, CD11c
and F4/80 used to identify myeloid subsets. Staining for CD3 and CD19 expression on the
gated CD11b-CD11c- population was used to identify lymphoid cells. Three separate grafts
from individual mice were analysed and cell composition compared with spleen leukocytes
from adult C57BL/6J and NOD/SCID mice.
(PDF)
S4 Fig. Limited hematopoietic tissue growth with 5G3 stroma grafting. 5G3 stromal cells
were grown on a collagen sponge ahead of transplantation under the kidney capsule of NOD/
SCID (CD45.1) mice. Grafts were dissected out after 4 weeks and cells dissociated for antibody
staining and flow cytometry. Live singlets were gated, and CD11b, CD11c and F4/80 staining
was used to identify myeloid cell subsets. Staining for CD3 and CD19 expression on the gated
CD11b-CD11c- population was used to identify lymphoid cells. Three individual grafts trans-
planted under the kidney capsule of a single mouse were analysed, and cell composition com-
pared with splenic leukocytes from adult C57BL/6J and NOD/SCID mice.
(PDF)
S1 Table. Summary of individual grafting experiments. The 5G3 and 3B5 stromal cells were
harvested and prepared for grafting by either overnight cultures on a collagen sponge, or by
mixing with Matrigel ahead of surgical implantation under the kidney capsule of NOD/SCID
mice.
(PDF)
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